di , 06/02/2024

Cedars-Sinai, a renowned healthcare institution, introduces a groundbreaking application leveraging Apple Vision Pro technology to provide unparalleled mental health support. Named Xaia, which stands for eXtended-Reality Artificially Intelligent Ally, this innovative app combines generative artificial intelligence and spatial computing to offer patients immersive therapy experiences.

Xaia takes advantage of Apple Vision Pro‘s unique capabilities, providing patients with self-administered, AI-enabled, conversational therapy in immersive spatial environments. Users can choose serene settings such as a creek-side meadow or a sunny beach retreat to engage in therapeutic activities, including deep breathing exercises and meditation.

Dr. Brennan Spiegel, MD, MSHS, professor of medicine and director of health services research at Cedars-Sinai, expressed excitement about the transformative potential of Xaia, citing Apple Vision Pro’s remarkable display capabilities as a gateway to immersive behavioral health support.

Apple Vision Pro offers a gateway into Xaia’s world of immersive, interactive behavioral health support, making strides that I can only describe as a quantum leap beyond previous technologies.

Dr. Omer Liran, MD, a psychiatrist at Cedars-Sinai and co-founder of Xaia, emphasized the app’s aim to democratize mental wellness by making quality therapy accessible to all individuals.

Apple Vision Pro has allowed us to create a platform where technology fades into the background and the user’s healing journey comes to the forefront.

Leveraging the power of Apple Vision Pro, Xaia prioritizes the user’s healing journey, fostering a deeply personalized therapeutic experience.

The development of Xaia represents the culmination of years of rigorous research and clinical expertise, highlighted by a first-of-its-kind study published in Nature Digital Medicine, that demonstrated the app’s efficacy and safety for patient use.

Cedars-Sinai’s Technology Ventures played a crucial role in supporting the commercialization of Xaia, ensuring its potential to improve the quality of life for patients worldwide.

It’s noteworthy that Spiegel and Liran, co-founders of VRx Health, have exclusively licensed the Xaia technology from Cedars-Sinai for commercialization, marking a pivotal moment in the intersection of healthcare and technology.

With Xaia poised to redefine mental health support, Cedars-Sinai continues to pioneer innovative solutions that prioritize patient well-being and community health.

Conflicts of Interest: Spiegel and Liran are co-founders of VRx Health. The Xaia technology is exclusively licensed from Cedars-Sinai to VRx Health for commercialization.